Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Ann Surg. 2021 Dec 14;277(3):e592–e596. doi: 10.1097/SLA.0000000000005338

Table 4.

Association between Preoperative Liver Pathology and Grades B/C PHLF (n=1646)

Univariate OR 95% CI Adjusted OR a 95% CI
Tumor histology
CRLM 9.78 (2.33, 40.50) 3.34 (0.67, 16.55)
HCC 8.24 (1.98, 34.22) 2.40 (0.50, 11.58)
CCC 17.82 (4.26, 74.59) 6.38 (1.37, 29.70)
Benign 1.43 (0.24, 8.65) 1.16 (0.18, 7.44)
Other malignancy 7.50 (1.61, 34.93) 2.12 (0.40, 11.34)
Liver histology
Steatosis 1.85 (1.20, 2.85) 1.30 (0.80, 2.13)
Fibrosis/Cirrhosis 2.26 (1.52, 3.37) 1.93 (1.15, 3.22)
Chemotherapy 0.94 (0.58, 1.51) 0.60 (0.32, 1.09)
NALFD 2.84 (1.55, 5.18) 2.31 (1.16, 4.62)
a

Covariates: age, sex, year of operation, ASA, Charlson Comorbidity Index, segments resected, operative approach, previous abdominal surgery

OR: odds ratio; CI: confidence interval; CRLM: colorectal liver metastasis; HCC: hepatocellular carcinoma; CCC: cholangiocarcinoma; NAFLD: non-alcoholic fatty liver disease